Blog: Blog2

GPCR News

Crinetics Presents Clinical And Research Results At ENDO 2022

June 2022 "CRN04894 Selected for Oral Presentation SAN DIEGO, June 8, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), announced...

Jun 1, 20221 min read

1 view

0 comments

April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused...

Apr 1, 20221 min read

0 views

0 comments

March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief Commercial Officer "SAN DIEGO –...

Mar 1, 20221 min read

0 views

0 comments

December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company, Radionetics Oncology....

Dec 1, 20211 min read

1 view

0 comments